sulfinpyrazone has been researched along with Acute Myelogenous Leukemia in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Witwer, MW | 1 |
| Schmid, FR | 1 |
| Tesar, JT | 1 |
1 other study available for sulfinpyrazone and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Acute myelomonocytic leukaemia and multiple myeloma after sulphinpyrazone and colchicine treatment of gout.
Topics: Aged; Colchicine; Gout; Humans; Leukemia, Myeloid, Acute; Male; Multiple Myeloma; Sulfinpyrazone | 1976 |